Search Prime Contracts

140D042590005

Other Transaction Agreement

Overview

Government Description
CRISPR DELIVERY AND MANUFACTURING INNOVATION FOR MINIMAL-COG CANCER AND HIV THERAPIES VIA IN VIVO IMMUNE ENGINEERING
Awardee
Global Life Sciences Solutions Usa
Awarding Agency
Interior Business Center (IBC) [DOI]
Funding Agency
National Institutes of Health (NIH) [HHS]
NAICS
Not Reported
PSC
AN13 - Health R&D Services; Health Care Services; Experimental Development
Place of Performance
Marlborough, MA 1752 United States
Pricing
Other
Set Aside
None
Extent Competed
Competed
Related Opportunity
None
Global Life Sciences Solutions Usa was awarded Other Transaction Agreement 140D042590005 140D042590005 for Crispr Delivery And Manufacturing Innovation For Minimal-Cog Cancer And Hiv Therapies Via In Vivo Immune Engineering worth up to $40,130,860 by the National Institutes of Health in September 2025. The contract has a duration of 6 years and was awarded full & open with PSC AN13 via program solicitation acquisition procedures. As of today, the Other Transaction Agreement has a total reported backlog of $24,220,170.

Status
(Open)

Last Modified 9/25/25
Period of Performance
9/25/25
Start Date
9/24/27
Current End Date
9/24/31
Potential End Date
0% Complete

Obligations and Backlog
$15.9M
Total Obligated
$15.9M
Current Award
$40.1M
Potential Award
40% Funded
$0.0
Funded Backlog
$24.2M
Total Backlog

Award Hierarchy

Other Transaction Agreement

140D042590005

Subcontracts

0

OTA Details

Type of Agreement
Prototype
Non-Governmental Funding
None Reported
Non-Traditional Participation
Non-Traditional Significant Participation

Activity Timeline

Interactive chart of timeline of amendments to 140D042590005

People

Suggested agency contacts for 140D042590005

Competition

Number of Bidders
Not Applicable
Solicitation Procedures
Program Solicitation
Evaluated Preference
None
Commercial Item Acquisition
None
Simplified Procedures for Commercial Items
None

Other Categorizations

Subcontracting Plan
Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Large Business
Awardee UEI
FG41DG32EGC3
Awardee CAGE
00JR1
Agency Detail
Awarding Office
140D04 IBC ACQ SVCS DIRECTORATE (00004)
Funding Office
75N992
Created By
decarloj
Last Modified By
decarloj
Approved By
decarloj

Legislative

Legislative Mandates
None Applicable
Performance District
MA-03
Senators
Edward Markey
Elizabeth Warren
Representative
Lori Trahan
Modified: 9/25/25